1. Home
  2. CHPT vs AURA Comparison

CHPT vs AURA Comparison

Compare CHPT & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHPT
  • AURA
  • Stock Information
  • Founded
  • CHPT 2007
  • AURA 2007
  • Country
  • CHPT United States
  • AURA United States
  • Employees
  • CHPT N/A
  • AURA N/A
  • Industry
  • CHPT Industrial Specialties
  • AURA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHPT Consumer Discretionary
  • AURA Health Care
  • Exchange
  • CHPT Nasdaq
  • AURA Nasdaq
  • Market Cap
  • CHPT 340.1M
  • AURA 396.8M
  • IPO Year
  • CHPT N/A
  • AURA 2021
  • Fundamental
  • Price
  • CHPT $11.55
  • AURA $5.76
  • Analyst Decision
  • CHPT Hold
  • AURA Strong Buy
  • Analyst Count
  • CHPT 11
  • AURA 7
  • Target Price
  • CHPT $18.40
  • AURA $22.29
  • AVG Volume (30 Days)
  • CHPT 490.7K
  • AURA 283.0K
  • Earning Date
  • CHPT 09-03-2025
  • AURA 11-11-2025
  • Dividend Yield
  • CHPT N/A
  • AURA N/A
  • EPS Growth
  • CHPT N/A
  • AURA N/A
  • EPS
  • CHPT N/A
  • AURA N/A
  • Revenue
  • CHPT $397,731,000.00
  • AURA N/A
  • Revenue This Year
  • CHPT N/A
  • AURA N/A
  • Revenue Next Year
  • CHPT $11.08
  • AURA N/A
  • P/E Ratio
  • CHPT N/A
  • AURA N/A
  • Revenue Growth
  • CHPT N/A
  • AURA N/A
  • 52 Week Low
  • CHPT $8.55
  • AURA $4.35
  • 52 Week High
  • CHPT $30.00
  • AURA $12.38
  • Technical
  • Relative Strength Index (RSI)
  • CHPT 60.54
  • AURA 37.10
  • Support Level
  • CHPT $10.62
  • AURA $5.93
  • Resistance Level
  • CHPT $12.40
  • AURA $6.28
  • Average True Range (ATR)
  • CHPT 0.62
  • AURA 0.26
  • MACD
  • CHPT -0.01
  • AURA -0.02
  • Stochastic Oscillator
  • CHPT 62.46
  • AURA 5.22

About CHPT ChargePoint Holdings Inc.

ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: